Cell having modified cell membrane

Details Cell having modified cell membrane Cell having modified cell membrane

2007-04-03

2007-04-03

Lankford, Jr., Leon B (Department: 1651)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

C435S243000

Reexamination Certificate

active

10211587

ABSTRACT:
A cell in which a reaction product of a substance to be modified and an amphipathic compound is non-covalently bound to a cell membrane, wherein said compound has the following features:(1) having one or more aliphatic hydrocarbon groups at one end;(2) having one or more portions containing a hydrophilic group in a molecule; and(3) having one or more reactive functional groups which are capable of covalently binding with the substance to be modified at an end different from the end in the above (1).

REFERENCES:
patent: 6051207 (2000-04-01), Klaveness et al.
patent: 6261537 (2001-07-01), Klaveness et al.
patent: 6264914 (2001-07-01), Klaveness et al.
patent: 6264917 (2001-07-01), Klaveness et al.
patent: 6309633 (2001-10-01), Ekwuribe et al.
patent: 2001/0016587 (2001-08-01), Klaveness et al.
patent: 2002/0102215 (2002-08-01), Klaveness et al.
patent: 2002/0102217 (2002-08-01), Klaveness et al.
patent: 2002/0165205 (2002-11-01), Kubo et al.
patent: 1241172 (2002-09-01), None
patent: 2002-037883 (2002-02-01), None
patent: 97/32617 (1997-09-01), None
patent: 98/18501 (1998-05-01), None
patent: 00/78302 (2000-12-01), None
English Language Abstract of JP 2002-037883.
Bendas et al., “Targetability of Novel Immunoliposomes Prepared by a New Antibody Conjugation Technique”, International Journal of Pharmaceutics, vol. 181, No. 1, Apr. 20, 1999, pp. 79-93.
Torchilin et al., “p-Nitrophenylcarbonyl-PEG-PE-liposomes: Fast and Simple Attachment of Specific Ligands, Including Monoclonal Antibodies, to Distal Ends of PEG Chains Via p-nitrophenylcarbonyl Groups”, Biochimica Et Biophysica Acta, vol. 1511, No. 2, Apr. 2, 2001, pp. 397-411.
M. Edward Medof et al., “Cell-Surface Engineering with GPI-Anchored Proteins”, FASEB, vol. 10, pp. 574-586 (1996).
Christina L. Van Broekhoven et al., “Engrafting Costimulator Molecules onto Tumor Cell Surfaces with Chelatro Lipids: A Potentially Convenient Approach in Cancer Vaccine Development”, The Journal of Immunology, vol. 164, pp. 2433-2443 (2000).
Polymer Preprints, Japan, vol. 47, No. 10, pp. 2499-2500 (1998), accompanied by an English Language Abstract.
Tanpaku-shitsu, kakusan, kohso,vol. 45, No. 11, pp. 1859-1864 (2000), accompanied by an English Language Abstract.

Affiliated with

Also associated with

Rating

Cell having modified cell membrane does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cell having modified cell membrane, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell having modified cell membrane will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3770804